4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-001375
CEO and CFO bought 1,000 shares at $19.99 ($19,990)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-01-13 | Purchase | +1,000 | $19.99 | $19,990 | 1,194,429 | D |
| Open-market purchases · 1,000 sh · avg $19.99 · $19,990 | |||||||
Loading xslF345X03/ownership.xml…